Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Natural Sciences Engineering and Technology Journal
Bharmatisna Anggaharsya Nugraha
Departement of Neurology, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
Aerospace Engineering Astronomy Automotive Engineering Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Civil Engineering, Building, Construction & Architecture Computer Science & IT Control & Systems Engineering Decision Sciences, Operations Research & Management Dentistry Earth & Planetary Sciences Electrical & Electronics Engineering Energy Immunology & microbiology Industrial & Manufacturing Engineering Library & Information Science Materials Science & Nanotechnology Mechanical Engineering Medicine & Pharmacology Neuroscience Physics Social Sciences Transportation

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Genetic Variants of Butyrylcholinesterase and Their Potential Impact on Human Health: A Narrative Literature Review Bharmatisna Anggaharsya Nugraha
Natural Sciences Engineering and Technology Journal Vol. 1 No. 1 (2021): Natural Sciences Engineering and Technology Journal
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/nasetjournal.v1i1.5

Abstract

Butyrylcholinesterase (BChE) is an enzyme found in plasma and many other parts of the body. It is an enzyme that hydrolyses drugs containing ester bonds, such as drugs acting at the neuromuscular junction and local anaesthetic agent. This literature review aimed to describe genetic variants of butyrylcholinesterase. BChE polymorphisms have been shown to produce enzymes with varying levels of catalytic activity. Analysis of butyrylcholinesterase involves the determination of both enzyme activity and biochemical phenotypes. Phenotype is determined by the use of specific enzyme inhibitors (such as dibucaine or fluoride) that produce phenotype-specific patterns of dibucaine or fluoride numbers. Molecular genetic analyses can determine the true genotypes. In conclusion, genetic variants of human butyrylcholinesterase were one of the first examples in the new field of pharmacogenetics when it was recognized that abnormal response to succinylcholine was due to a mutated enzyme with low binding affinity.
Co-Authors